Filing Details

Accession Number:
0001209191-21-061093
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-19 21:12:35
Reporting Period:
2021-10-18
Accepted Time:
2021-10-19 21:12:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1563880 Trevi Therapeutics Inc. TRVI Pharmaceutical Preparations (2834) 450834299
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746342 Carmen Chang 2855 Sand Hill Road
Menlo Park CA 94025
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-18 1,851,852 $0.00 7,789,850 No 4 P Indirect See Note 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Note 2
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock 3.5-Year Common Stock Warrant Acquisiton 2021-10-18 1,851,852 $0.00 1,851,852 $1.37
Common Stock 7-Year Common Stock Warrant Acquisiton 2021-10-18 1,851,852 $0.00 1,851,852 $1.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,851,852 2021-10-18 2025-04-18 No 4 P Indirect
1,851,852 2021-10-18 2028-10-18 No 4 P Indirect
Footnotes
  1. Represents securities acquired pursuant to a Securities Purchase Agreement (the "SPA"), dated October 15, 2021, by and between the Issuer and New Enterprise Associates 16, L.P. ("NEA 16"), with a closing on October 18, 2021. Pursuant to the terms of the SPA, NEA 16 purchased common units for $1.62 per common unit. Each common unit consisted of one share of the Issuer's common stock, one 3.5 year common stock warrant, and one 7-year common stock warrant.
  2. The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of NEA 16, the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.